A similar statistically significant decline was seen for morning serum 17-hydroxyprogesterone (17-OHP), a secondary endpoint ... to Crinetics’s (CRNX) recent gains. “Net net, expectations ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback